Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infusion rate and volume kinetics for hyperoncotic albumin in healthy subjects (RAV)
2017-003687-12Phase 4Completed
- Sponsor
- Region Östergötland
- Start
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) (2 arms), sponsored by Region Östergötland. Primary endpoint: Difference in tissue fluid recruitment by infusion rate. Started Sep 2017; status: completed.
02
Drugs
albumin (human)
Beyond the preview
Go deeper on 2017-003687-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003687-12.